<DOC>
	<DOCNO>NCT01448057</DOCNO>
	<brief_summary>The study clinical evaluation counter ( OTC ) combination product contain paracetamol ( 500 mg ) , dimethindene maleate ( 1 mg ) , phenylephrine hydrochloride ( 10 mg ) compare paracetamol ( 500 mg ) alone treatment nasal congestion , rhinorrhea , sneeze symptom due upper respiratory tract infection ( URTI ) .</brief_summary>
	<brief_title>Evaluation Efficacy Safety Tablets Paracetamol , Dimethindene Maleate Phenylephrine Hydrochloride Reducing Symptoms Common Cold Flu</brief_title>
	<detailed_description />
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Sneezing</mesh_term>
	<mesh_term>Phenylephrine</mesh_term>
	<mesh_term>Oxymetazoline</mesh_term>
	<mesh_term>Dimethindene</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Inclusion criterion : â€¢ acute URTI , diagnose health care professional study site , follow symptom start within 72 hour screening/baseline Visit : nasal congestion , sneeze , rhinorrhea . Exclusion criterion : Use investigational drug within 30 day 10 halflives enrollment , whichever longer . History known hypersensitivity study drug , excipients drug similar chemical class . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Paracetamol</keyword>
	<keyword>dimethindene maleate</keyword>
	<keyword>phenylephrine hydrochloride</keyword>
	<keyword>cold flu symptom</keyword>
</DOC>